Product NDC: | 37000-731 |
Proprietary Name: | SK-II Facial Treatment |
Non Proprietary Name: | Octinoxate |
Active Ingredient(s): | 10.9; 81.64; 42.728 mg/mL; mg/mL; mg/mL & nbsp; Octinoxate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | LOTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 37000-731 |
Labeler Name: | Procter & Gamble Manufacturing Co. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20091101 |
Package NDC: | 37000-731-30 |
Package Description: | 1 BOTTLE, DISPENSING in 1 CARTON (37000-731-30) > 30 mL in 1 BOTTLE, DISPENSING |
NDC Code | 37000-731-30 |
Proprietary Name | SK-II Facial Treatment |
Package Description | 1 BOTTLE, DISPENSING in 1 CARTON (37000-731-30) > 30 mL in 1 BOTTLE, DISPENSING |
Product NDC | 37000-731 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Octinoxate |
Dosage Form Name | LOTION |
Route Name | TOPICAL |
Start Marketing Date | 20091101 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Procter & Gamble Manufacturing Co. |
Substance Name | ENSULIZOLE; OCTINOXATE; ZINC OXIDE |
Strength Number | 10.9; 81.64; 42.728 |
Strength Unit | mg/mL; mg/mL; mg/mL |
Pharmaceutical Classes |